PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.12 and traded as high as $0.13. PURE Bioscience shares last traded at $0.12, with a volume of 69,400 shares traded.
PURE Bioscience Trading Down 4.5 %
The firm has a market capitalization of $13.78 million, a P/E ratio of -3.08 and a beta of 0.13. The company’s fifty day simple moving average is $0.10 and its 200 day simple moving average is $0.12.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last issued its quarterly earnings data on Wednesday, June 14th. The company reported ($0.01) EPS for the quarter. PURE Bioscience had a negative return on equity of 151.03% and a negative net margin of 247.89%. The company had revenue of $0.41 million during the quarter.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Stories
- Five stocks we like better than PURE Bioscience
- How to Invest in Energy
- 8 Best Meme Stocks to Buy Now
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Is Now The Time To Buy XLF Financial ETF?
- The “How” and “Why” of Investing in 5G Stocks
- Three Ways To Play The Rise In Oil Prices
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
